NRP1 and neoplasm: Fusion of tLyP-1 to human ferritin nanospheres further augments cellular uptake and tumor penetration, while NRP-1 targeting in CD8+ T cells enhances PD-1 blockade efficacy and promotes long-term immune memory [92].